Efficacy of ibrutinib in the treatment of <scp>B</scp>ing–<scp>N</scp>eel syndrome

Aurélie Cabannes‐Hamy, Richard Lemal, Lauriane Goldwirt, Stéphanie Poulain, Sandy Amorim, Renan Pérignon, Juliette Berger, Pauline Brice, Eric De Kerviler, Jacques‐Olivier Bay, Helene Sauvageon, Kheira Beldjord, Samia Mourah, Olivier Tournilhac, Catherine Thieblemont

doi:10.1002/ajh.24279

Efficacy of ibrutinib in the treatment of <scp>B</scp>ing–<scp>N</scp>eel syndrome

DOI Web Site Web Site 被引用文献3件

Aurélie Cabannes‐Hamy

APHP, Department of Hemato‐Oncology Hopital Saint‐Louis Paris France
Richard Lemal

CHU Clermont‐Ferrand Service D'hématologie Clinique Adulte Et De Thérapie Cellulaire Clermont‐Ferrand 63003 France
Lauriane Goldwirt

APHP, Department of Pharmacology Hopital Saint‐Louis Paris France
Stéphanie Poulain

Centre Hospitalier De Valenciennes Service d'Hématologie‐Immunologie‐Cytogénétique Valencia France
Sandy Amorim

APHP, Department of Hemato‐Oncology Hopital Saint‐Louis Paris France
Renan Pérignon

CHU Clermont‐Ferrand, Pôle De Radiologie Clermont‐Ferrand 63003, France
Juliette Berger

Hématologie Biologique, Centre De Ressources Biologiques D'auvergne CHU Clermont‐Ferrand Clermont‐Ferrand 63003, France
Pauline Brice

APHP, Department of Hemato‐Oncology Hopital Saint‐Louis Paris France
Eric De Kerviler

APHP, Department of Radiology Hopital Saint‐Louis Paris France
Jacques‐Olivier Bay

CHU Clermont‐Ferrand Service D'hématologie Clinique Adulte Et De Thérapie Cellulaire Clermont‐Ferrand 63003 France
Helene Sauvageon

APHP, Department of Pharmacology Hopital Saint‐Louis Paris France
Kheira Beldjord

EA7324, Paris Descartes Université Sorbonne Paris Cité, Paris France
Samia Mourah

APHP, Department of Pharmacology Hopital Saint‐Louis Paris France
Olivier Tournilhac

CHU Clermont‐Ferrand Service D'hématologie Clinique Adulte Et De Thérapie Cellulaire Clermont‐Ferrand 63003 France
Catherine Thieblemont

APHP, Department of Hemato‐Oncology Hopital Saint‐Louis Paris France